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Two cDNA subfragments containing the cell-attachment site of human fibronectin (FN) were expressed 
as Sgalactosidase fusion proteins in E. cofi. The products were purified to homogeneity by monoclonal anti- 
body affinity chromatography and assayed for activity in a standard cell-adhesion assay. A fusion protein 
containing an 80 kDa fragment of human FN appeared functionally equivalent to intact FN purified from 
human plasma, whereas a truncated fusion protein of 33 kDa still containing a previously postulated cell- 
attachment site was approx. W-fold less active. Our study establishes a system for analyzing adhesive pro- 
tein function by DNA manipulation, rules out any major role for eukaryotic post-translational modifica- 
tions in FN adhesive function, and localizes additional functional activity to a 1.3 kb region. 
Fibronectin; cDNA; Cell adhesion; (E. coli, Human) 
1. INTRODUCTION 
The glycoprotein fibronectin (FN) is a multi- 
functional extrace~ular protein composed of 
several functions domains, including sites for 
binding to fibrin, collagens, heparin, and the cell 
surface [l-4]. The latter cell-binding or adhesive 
recognition site is of particular interest, since in- 
hibitors of FN interactions with cells can inhibit 
crucial steps in embryonic development or 
metastasis (e.g. see references in [5]). The sequence 
(Gly)-Arg-Gly-Asp-Ser is a key cell-attachment site 
[4]. However, this sequence and an 11.5 kDa pep- 
sin fragment containing the putative cell- 
Correspondence address: M. Obara, Laboratory of 
Mofeeular Biology, National Cancer Institute, National 
Institutes of Health, Bethesda, MD 20892, USA 
attachment site show IO-lOO-fold lower affinities 
for the FN receptor than intact FN or fragments of 
275 kDa [6]. 
The primary sequence information and post- 
translational modi~~ations required for FN 
adhesive function might be analyzed most effec- 
tively using an expression system in which protein 
length and primary sequence could be controlled at 
will, i.e. by DNA manipulation. We report here 
the expression of cell-binding domain sequences of 
human FN in E. coii under the control of the right 
arm promoter of the hgtll phage vector. One of 
the affinity-purified products appears to be nearly 
functionally equivalent to the native human FN 
molecule in a standard adhesion assay. We also ex- 
amine for functional roles of the amino-terming 
region of this domain and of post-translational 
modifications. 
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2. MATERIALS AND METHODS 2.4. ~u~c~oning and DNA sequencing 
2.1. Preparation of FN cDNA clone pFH60 
An FN cDNA clone spanning 60% of the total 
FN protein sequence (pFH60) was prepared by 
ligating two existing cDNA clones, pFH1 and. 
pFHlS4 [7]. The ClaI-BamHI fragment (2 kb) of 
pFH1 was subcloned into pUC19 as were the SacI- 
BarnHI (1.2 kb) and HindHI-BumHI (1.3 kb) 
fragments of pFHl54. The pFH1 insert was ex- 
cised with SacI-Xpnf and ligated to the 1.3 kb 
pFH154 insert, then to the 1.2 kb insert in pUC19. 
Purified recombinant phage DNA was digested 
with EcoRI and subcloned into Ml3 vectors. DNA 
sequencing was performed by the method of 
Sanger et al. [9] using [m-35S]thio-dATP 
(Amersham). 
3. RESULTS AND DISCUSSION 
2.2. Construction and antibody screening of Xgtll 
subclones 
The cDNA inserts isolated by double digestion 
of pFH60 DNA with HindIII-EcoRV or BamHI- 
EcoRV were subcloned at the EcoRI site of the 
hgtll vector as described by Young and Davis [8] 
using a mixture of 8, lo- and 12-mer EcoRI 
linkers (Pharmacia) to obtain a correct reading 
frame. 
Two human FN cDNA fragments containing the 
region encoding the (Gly)-Arg-Gly-Asp-Ser cell- 
binding site and adjacent sequences were sub- 
cloned into the EcoRI site of the hgtl 1 phage vec- 
tor to obtain expression as @-galactosidase fusion 
proteins (fig.1). Lysogen clones of each recombi- 
nant phage in E. coli were isolated and cultured in 
the presence of IPTG to induce the production of 
fusion proteins. 
Rccombin~t phages producing fi-galactosidase- 
fused human FN segments in E. coli strain Y 1090 
were identified using rabbit anti-human plasma FN 
antibody with the ProtoBlot hgtl 1 immunoscreen- 
ing system (Promega Biotec). 
2.3, Isolation and purification of fl-galactosidase 
fusion proteins 
Fusion proteins expressed in E. coli were ana- 
lyzed by inducing lysogens in strain Y 1089 [8]. The 
E. coli cells were lysed by incubating with lysozyme 
(2000 U/ml of original culture) and sonication 
(2 min) in 10 mM Tris-HCl (pH 8.0), 100 mM 
NaCl, 1 mM EDTA (STE), adjusted to 8 M urea 
in STE, incubated for 15 min at S*C, and clarified 
by ultracentrifugation. The supernatants were mix- 
ed with an equal volume of STE and stored at 
- 85°C. 
FN-containing fragments were purified using 
monoclonal antibody 333 [6] coupled to Sepharose 
4B. After incubation for 2 h at 5”C, unadsorbed 
proteins were eluted with 2 M urea in STE and 
then with STE. The fusion proteins retained by the 
affinity matrix were eluted with 0.1 M 
diethyl~ine (pH 1 l-4), and adjusted to pH 8.0 
with 0.1 M Tris-HCl. Purity of the purified pro- 
teins was analyzed by SDS-polyacrylamide gel elec- 
trophoresis 161. 
Fig.2 shows high production of each fusion pro- 
tein; for example, the hCBD20 clone produced a 
product accounting for approx. 10% of total E. 
coli protein. The fusion proteins were purified to 
apparent homogeneity according to SDS- 
polyacrylamide gel electrophoresis by affinity 
chromatography using immobilized monoclonal 
antibody 333 (fig.2); this rat monoclonal antibody 
binds near the cell-binding site and is known to in- 
hibit fibroblast adhesion to human FN [6]. 
These highly purified proteins were assayed for 
biological activity with BHK cells using a standard 
adhesion assay measuring the extent of cell 
spreading [6]. FN purified from human plasma 
was used as a standard in the assay. As shown in 
table 1, the XCBDl fusion protein containing 
Fig.1. Schematic representation of Agtl I clones 
containing the cell-binding domain of human FN. The 
pFH60 cDNA clone covering -60% of the mature 
mRNA (n, see 171) was subcloned into Xgtil for 
kxpression. Subclones (-) contained bp 2813-5172 
(EcoRV, A) for hCBD1 or bp 4086-5172 for XCBD20, 
respectively. Arrow indicates cell-attachment site. 
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Fig.2. Purification of fusion proteins from two human 
FN cDNA subclones. Fusion proteins were expressed, 
purified, and analyzed electrophoretically (see text). 
Lanes: 1,5, IPTG-induced clone hCBD1 lysate; 2,6, 
IPTG-induced clone ACBDZO lysate; 3,7, affinity- 
purified hCBD1 fusion protein; 4,8, affinity-purified 
ACBDZO fusion protein. Proteins were visualized by 
silver staining (lanes l-4; Bio-Rad) or Coomassie blue 
(lanes 5-8). The blurry ‘band’ of -60 kDa seen in lanes 
5-8 is a silver-staining artifact also found in blank 
2OOk- . 
Coomaie Silver 
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-32% of the total FN cDNA sequence was nearly 
as active on a molar basis as fibronectin itself. In 
contrast, the ACBD20 fusion protein containing 
the entire sequence of a previously postulated cell- 
sample buffer lanes. 
attachment fragment [lo], but missing adjacent N- 
terminal sequences encoded by bp 2813-4086 in 
GeneBank file HUMFNMC [7], displayed a 
50-60-fold loss of activity. Since ELISA assays of 
adsorbed proteins confirmed that these proteins at- 
tached equally to substrates (not shown), our 
results appear to provide the most direct evidence 
to date for an important functional role for this 
1.3 kb region. In addition, these results using E. 
coli indicate that all of the eukaryotic post- 
translational modifications of FN [l-3], including 
N- and O-linked glycosylation and phosphoryla- 
tion, do not appear to be required for expression 
of virtually full functional activity of FN in this 
standard assay. The slight reduction of activity we 
observe may result from absence of N-linked car- 
bohydrates [1 I]. This system should permit further 
detailed analyses of the molecular basis of FN 
function. 
Table 1 
Activities of fusion protein? 
Protein Specific activity 
(50% cell spreading/pmol) 
Expt 1 Expt 2 Average, 
expts 1,2 
Relative 
specific 
activity 
Fibronectin 1.67 1.00 1.34 74 
ACBDl 1.18 0.78 0.98 54 
ACBDZO 0.019 0.017 0.018 1 
&Galactosidase 0.00 0.00 0.00 0 
a An average of 1000 cells were counted for each protein concentration 
assayed (-7000 cells/protein) 
CBD, cell-binding domain 
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